Modelling cost-effectiveness and value of information in clinical trials to inform stop go decisions: results from the arctic study

被引：0
|
作者：
Smith, Alison [1 ]
Hall, Peter [2 ]
O'Dwyer, John [1 ]
Hulme, Claire [1 ]
Cohen, Dena [1 ]
Gregory, Walter [1 ]
机构：
[1] Univ Leeds, York, N Yorkshire, England
[2] Univ Edinburgh, Edinburgh, Midlothian, Scotland
来源：
TRIALS | 2015年 / 16卷
关键词：
Chronic Lymphocytic Leukaemia; Mitoxantrone; Interim Analysis; Fludarabine; Health Loss;
D O I：
10.1186/1745-6215-16-S2-O27
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
O27
引用
收藏
页数：1
相关论文
共 50 条
  • [21] COST-EFFECTIVENESS OF VALSARTAN IN JAPAN: RESULTS FROM THE JIKEI HEART STUDY
    Shimizu, M.
    Crawford, B.
    Ikewaki, K.
    Taniguchi, I
    Kamae, I
    Dahlof, B.
    Drost, P.
    Mochizuki, S.
    VALUE IN HEALTH, 2009, 12 (03) : A151 - A151
  • [22] Cost-effectiveness of a Community-based Hypertension Improvement Project (ComHIP) in Ghana: results from a modelling study
    Pozo-Martin, Francisco
    Akazili, James
    Der, Reina
    Laar, Amos
    Adler, Alma J.
    Lamptey, Peter
    Griffiths, Ulla K.
    Vassall, Anna
    BMJ OPEN, 2021, 11 (09):
  • [23] Potential Cost-Effectiveness of Maternal Influenza Immunisation in Low-Income Countries: An Explorative Modelling Study and Value of Information Analysis to Guide Future Clinical Research
    Wang, Yingying
    Giles, Michelle L.
    Carvalho, Natalie
    VACCINES, 2024, 12 (03)
  • [24] Schizophrenia interventions in Vietnam: Primary results from a cost-effectiveness study
    Nguyen Quynh Anh
    Bui Ngoc Linh
    Nguyen Thu Ha
    Phanthunane, Pudtan
    Nguyen Thanh Huong
    GLOBAL PUBLIC HEALTH, 2015, 10 : S21 - S39
  • [25] From basic research to cost-effectiveness trials: the needed spirit to promote clinical nutrition
    Pichard, C
    Genton, L
    CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2005, 8 (04): : 373 - 376
  • [26] COST-EFFECTIVENESS OF CHEMOPREVENTION WITH DUTASTERIDE BASED ON RESULTS FROM THE REDUCE CLINICAL TRIAL
    Earnshaw, S. R.
    McDade, C. L.
    Black, L.
    Kattan, M. W.
    VALUE IN HEALTH, 2009, 12 (07) : A271 - A271
  • [27] BIA RESULTS COULD STOP INTRODUCTION OF COST-EFFECTIVENESS THERAPY INTO STANDARD TREATMENT: EXAMPLE FROM CROATIA
    Culig, J.
    Leppee, M.
    Vrca, V.
    VALUE IN HEALTH, 2011, 14 (07) : A469 - A469
  • [28] Group cognitive behavioural therapy for postnatal depression: a systematic review of clinical effectiveness, cost-effectiveness and value of information analyses
    Stevenson, M. D.
    Scope, A.
    Sutcliffe, P. A.
    Booth, A.
    Slade, P.
    Parry, G.
    Saxon, D.
    Kalthenthaler, E.
    HEALTH TECHNOLOGY ASSESSMENT, 2010, 14 (44) : IX - +
  • [29] STATIN COST-EFFECTIVENESS IN PATIENTS WITH PREVIOUS CORONARY HEART DISEASE: A SYSTEMATIC REVIEW OF THE COST-EFFECTIVENESS ANALYSIS DERIVED FROM SINGLE RANDOMISED CLINICAL TRIALS
    Luque, A.
    Nobre, M. R. C.
    VALUE IN HEALTH, 2013, 16 (07) : A529 - A529
  • [30] Modelling the cost-effectiveness of rosiglitazone and metformin combination therapy using results from the RECORD ABPM sub-study
    Beale, S.
    Bagust, A.
    Home, P.
    Da Costa, S. Mendes
    Shearer, A.
    DIABETES, 2006, 55 : A555 - A556
12345